[Successful defibrillation by disconnection of superior vena cava electrode for high defibrillation threshold: a case

Kohei Matsushita1, Toshiyuki Ishikawa, Shinichi Sumita

  • 1The Second Department of Internal Medicine, Yokohama City University School of Medicine, Yokohama. koheimat@ya2.so-net.ne.jp

Journal of Cardiology
|February 11, 2005
PubMed

Insights

A patient with heart disease experienced challenges with defibrillation despite an implantable cardioverter-defibrillator. Disconnecting a specific electrode was necessary for successful defibrillation, highlighting device optimization needs.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • A 72-year-old male patient diagnosed with dilated cardiomyopathy and sustained ventricular tachycardia was undergoing amiodarone treatment.
  • The patient presented with loss of consciousness, and electrocardiography revealed a 2:1 atrioventricular block.

Observation:

  • Electrophysiological study induced various ventricular tachyarrhythmias, including ventricular tachycardia and ventricular fibrillation.
  • An implantable cardioverter-defibrillator (ICD) was implanted for arrhythmia management.
  • Defibrillation threshold testing revealed inability to terminate ventricular fibrillation with maximal ICD output (31J).

Findings:

  • Standard adjustments in electrode polarity and position failed to achieve stable defibrillation.
  • Successful defibrillation was ultimately accomplished only after disconnecting the superior vena cava electrode.

Implications:

  • This case underscores the complexity of achieving effective defibrillation in challenging patient populations.
  • It highlights the potential need for unconventional approaches, such as lead modification, in ICD therapy.
  • Further research into optimizing ICD lead configurations and defibrillation strategies is warranted.

Related Concept Videos

Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...